Paranovus Entertainment Technology Ltd.
NASDAQ:PAVSMedical - Pharmaceuticals
+$1.28 today
- Market cap
- $353.07M
- Beta
- -0.35
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$9.07
Volume 0.16M
Average 113.44M
PAVS Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Paranovus Entertainment Technology Ltd.NASDAQ: PAVS
Gross Profit · Q2 FY2025 · quarter ended Sep 2025
Gross profit turns positive
Q2 FY2025 gross profit was $1.4M, compared with -$180.72K a year earlier.
Context
- Gross profit amounted to 518.6% of revenue in FY2024.
- Gross profit increased in 1 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2024
- (370.98K) USD
- Year-over-year change
- +2.4%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | (370.98K) | +2.4% |
| FY2023 | 2024-03-31 | (380K) | -191.2% |
| FY2022 | 2023-03-31 | 416.88K | -88.8% |
| FY2021 | 2022-03-31 | 3.71M | -79.6% |
| FY2020 | 2021-03-31 | 18.18M | — |
Gross Profit vs competitors
How PAVS compares with its peers on the latest reported figures
- PAVS's FY2024 gross profit of -$370.98K is the lowest of the 4 companies compared; the peer median is $18.64M.
- Its year-over-year change of +2.4% is the 2nd highest of 4, against a peer median of +0.2%.
- Gross profit amounts to 518.6% of revenue for PAVS, versus a peer median of 27.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
WYHGWing Yip Food Holdings Group Limited American Depositary Shares | LTM Mar 2026 | $36.3M | -12.5% | -2.5% | 27.5% |
| LTM Mar 2026 | $18.64M | +0.2% | +53.9% | 44.1% | |
| LTM Mar 2026 | $1.88M | +66.2% | — | 14.3% | |
| FY2024 | -$370.98K | +2.4% | — | 518.6% | |
| Peer median (excluding PAVS) | $18.64M | +0.2% | +25.7% | 27.5% | |
Competitors are the stored peer set for PAVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2020 Mar 2021 | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|---|
| Revenue | 71.48M | 89.49M | 23.33M | 0 | 71.54K |
| Cost of Revenue | 53.31M | 85.78M | 22.92M | 380K | 442.53K |
| Gross Profit | 18.18M | 3.71M | 416.88K | (380K) | (370.98K) |
| Gross Margin | 25.4% | 4.1% | 1.8% | — | -518.6% |
| Research & Development | 1.66M | 1.68M | 1.4M | 0 | 0 |
| Selling, General & Admin | 14.99M | 49.6M | 4.97M | 2.08M | 1.93M |
| Operating Expenses | 16.65M | 51.29M | 4.97M | 2.08M | 1.93M |
| Depreciation & Amortization | 880.88K | 2.19M | 58.75K | 380K | 380K |
| EBITDA | 2.41M | (45.39M) | (4.49M) | (2.08M) | (1.92M) |
| EBITDA Margin | 3.4% | -50.7% | -19.2% | — | -2682.4% |
| Operating Income | 1.53M | (47.58M) | (4.55M) | (2.46M) | (2.3M) |
| Operating Margin | 2.1% | -53.2% | -19.5% | — | -3213.6% |
| Interest Income | 131.9K | 108.4K | 316 | 0 | 156 |
| Interest Expense | 111.8K | 85.99K | 72.3K | 39.17K | 261.85K |
| Other Income / Expenses | 125.62K | (10.17M) | 22.04K | (1.83M) | (4.7M) |
| Income Before Tax | 1.65M | (57.75M) | (4.53M) | (4.29M) | (7M) |
| Pre-Tax Margin | 2.3% | -64.5% | -19.4% | — | -9788.2% |
| Income Tax Expense | 959.38K | (3.73M) | 3K | 0 | 0 |
| Net Income | 786.36K | (49.19M) | (71.74M) | (17.67M) | (7.53M) |
| Net Margin | 1.1% | -55.0% | -307.5% | — | -10519.7% |
| EPS (Basic) | 72.14 | (2,916.00) | (1,516.10) | (448.12) | (10.69) |
| EPS (Diluted) | 72.14 | (2,916.00) | (1,516.10) | (448.12) | (10.69) |
| Weighted Avg Shares | 10.9K | 16.86K | 47.31K | 39.43K | 704.27K |
| Weighted Avg Shares (Diluted) | 10.9K | 16.86K | 47.31K | 39.43K | 704.27K |
Paranovus Entertainment Technology Ltd.
NASDAQ:PAVS
Intrinsic Alpha fair value
Locked
Current Price
$7.02
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.